What Has Been The Historical And Current Growth Of The Malaria Treatment Market?
The malaria treatment market has seen considerable growth due to a variety of factors.
•In the past few years, the size of the market for malaria treatment has seen a consistent increase. This market is projected to experience a rise from $1.55 billion in 2024 to $1.62 billion in 2025, showcasing a compound annual growth rate (CAGR) of 4.9%.
Factors contributing to this growth during the historic period include the invention of potent medicines, concerted efforts in vector control, worldwide health campaigns, scientific investigations, and enhancements in health infrastructure.
What Is The Forecast For The Malaria Treatment Market By 2029?
The malaria treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The dimension of the market for treating malaria is predicted to experience substantial expansion in the upcoming years. The market is projected to escalate to a value of $2.07 billion in 2029, with a compound annual growth rate (CAGR) of 6.3%.
The growth during the predicted period can be associated with the monitoring of drug resistance, impacts of climate change, precision medicine and genomic methodologies, modifications in healthcare financing, and the inclusion of digital health solutions. The key trends to be observed during this period encompass the advancement of epidemiological surveillance, incorporating alternative medicine, development of vaccines against malaria, application of data in treatment plans, and implementation of education and training programs.
Which Drivers Are Accelerating Growth In The Malaria Treatment Market?
The upward trend in malaria cases is forecasted to catalyze the expansion of the marketplace for malaria treatment. Malaria, a potentially fatal ailment transmitted via mosquito bites and caused by the Plasmodium parasite, is marked by repeated fevers and symptoms resembling the flu. This growth can be traced back to factors such as poverty, inadequate healthcare access, climate shifts, absence of malaria prevention efforts, and drug resistance. Treatments for malaria offer an efficient method to manage and eradicate the infection instigated by the Plasmodium parasite. For example, the World malaria report of 2023, published by the World Health Organization based in Switzerland, revealed that global malaria cases hit 249 million in 2022, a surge of five million from 2021. Consequently, the increasing prevalence of malaria is a driving force behind the enlargement of the malaria treatment market.
What Are The Core Segments Of The Global Malaria Treatment Market?
The malaria treatment market covered in this report is segmented –
1) By Treatment: Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments
2) By Route Of Administration: Oral, Parenteral, Intravenous
3) By Distribution Channel: Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By End User: Hospitals, Specialty Clinics, Homecare, Other End Users
Subsegments:
1) By Prescription Medications: Antimalarial Drugs, Prophylactic Medications
2) By Vaccines: RTS,S Or AS01, Other Experimental Vaccines
3) By Diagnostic Tests: Rapid Diagnostic Tests, Microscopy-Based Tests, Polymerase Chain Reaction (PCR) Tests
4) By Other Treatments: Supportive Care, Herbal Remedies, Vector Control Measures
Pre-Book The Malaria Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Malaria Treatment Market Size?
Leading companies in the malaria treatment market are innovating with technologies such as the VERV Program. The aim is to boost the efficacy and efficiency of malaria diagnostics and treatments to ultimately alleviate the disease's impact in endemic areas. Initiated by the EPA, the VERV Program promotes the creation of new mosquito control products to combat diseases like malaria, offering fast-tracked review vouchers for registration. For example, in December 2023, the Vector Expedited Review Voucher (VERV) Program was launched by the US-based government agency, the Environmental Protection Agency (EPA). Financial incentives will be provided by the VERV Program to companies creating new pesticides aimed at mosquito populations resistant to conventional insecticides. The program will enable quicker registration processes for eligible products, thereby speeding up their market entry.
Who Are the Key Players in the Malaria Treatment Market?
Major companies operating in the malaria treatment market include:
• Pfizer Inc.
• Merck & Co.
• Johnson & Johnson
• Roche Holding AG
• Bayer AG
• Novartis AG
• Sanofi SA
• AstraZeneca Plc
• GlaxoSmithKline PLC.
• Takeda Pharmaceutical Company Limited
• Sumitomo Chemical Co. Ltd.
• Viatris Inc.
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Serum Institute of India
• Cipla Ltd.
• Amneal Pharmaceuticals LLC
• Lupin Ltd.
• Zydus Lifesciences Limited
• Ipca Laboratories Ltd.
• Chongqing Holley Pharmaceutical Co. Ltd.
• Zydus Lifesciences Ltd.
• Medicines Sans Frontières
• Strides Pharma Science Limited
• Swiss Tropical and Public Health Institute (Swiss TPH)
• AdvaCare Pharma USA LLC
• Medicines for Malaria Venture (MMV)
• VLP Therapeutics LLC
• Actiza Pharmaceutical Private Limited
What are the Regional Insights into the Malaria Treatment Market?
Middle East and Africa was the largest region in the malaria treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malaria treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
